Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:22:32 EST Mon 11 Nov 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
T:ATE
- ANTIBE THERAPEUTICS INC. J -
http://www.antibethera.com
09:22:32 EST
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
ATE
- T
↑ATS
12.0
0.09
H
0.09
18.5
0.295
1.23 0.15
Apr 08
Apr 24
15 min
RT 2¢
TSX - T
12.0
0.09
H
0.09
18.5
0.295
1.23 0.15
Apr 08
15 min
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information
Hide ATS
·
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
Company
·
Participants
·
1yr Bulletins
·
Sedar
·
Historical
·
Options
·
Shorts
·
Portfolio
Recent Trades - All 0 today
More trades...
Time ET
Ex
Price
Change
Volume
Buyer
Seller
Markers
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Price
Type
Headline
2024-04-24 20:19
C:ATE
0.295
Shares Delisted from TSX
222
Antibe Therapeutics to be delisted from TSX May 24
2024-04-24 13:43
C:ATE
0.295
News Release
200
Antibe's CCAA proceedings ended, receiver appointed
2024-04-19 11:23
C:ATE
0.295
News Release
200
Antibe Therapeutics obtains CCAA stay extension
2024-04-16 17:10
C:ATE
0.295
News Release
200
Antibe Therapeutics under review for listing on TSX
2024-04-09 19:06
C:ATE
0.295
News Release
200
Antibe Therapeutics granted initial order under CCAA
2024-04-09 16:24
C:ATE
0.295
Miscellaneous
270
Antibe Therapeutics under TSX delisting review
2024-04-09 09:35
C:ATE
0.295
News Release
200
Antibe to file for initial order under CCAA
2024-04-09 09:17
C:ATE
0.295
Halt Trading
170
Antibe Therapeutics halted at the open
2024-04-01 09:42
C:ATE
0.45
News Release
200
Antibe's otenaproxesul placed on clinical hold by FDA
2024-03-04 09:29
C:ATE
0.97
News Release
200
Antibe ordered to refund Nuance's $20M (U.S.) payment
2024-02-14 11:31
C:ATE
0.89
News Release
200
Antibe spends $2.3-million on R&D in Q3 2024
2024-02-14 06:35
C:ATE
0.89
SEDAR Interim MD & A
813
SEDAR Interim MD & A
2024-02-14 06:24
C:ATE
0.89
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements
2024-02-01 10:22
C:ATE
1.01
News Release
200
Antibe extends early warrant exercise incentive program
2023-12-29 09:41
C:ATE
0.94
News Release
200
Antibe arranges early warrant exercise program
2023-12-12 10:43
C:ATE
0.70
News Release
200
Antibe Therapeutics extends warrants to 2024
2023-11-13 11:37
C:ATE
0.93
News Release
200
Antibe spends $3.5M on R&D in fiscal Q2 2024
2023-11-13 06:36
C:ATE
0.93
SEDAR Interim MD & A
813
SEDAR Interim MD & A
2023-11-13 06:34
C:ATE
0.93
SEDAR Interim Financial Statements
812
SEDAR Interim Financial Statements